Viewing Study NCT01244633


Ignite Creation Date: 2025-12-25 @ 3:04 AM
Ignite Modification Date: 2026-02-05 @ 11:29 AM
Study NCT ID: NCT01244633
Status: COMPLETED
Last Update Posted: 2015-09-29
First Post: 2010-11-17
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Ecopipam Treatment of Tourette Syndrome
Sponsor: Psyadon Pharma
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Tourette's Syndrome View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Tourette's View
None Ecopipam View
None Dopamine receptors View
None Efficacy View
None Safety View
None Adults View